+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oxford Nanopore Technologies Plc (ONT) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 51 Pages
  • May 2024
  • GlobalData
  • ID: 5703380
Oxford Nanopore Technologies Plc (ONT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Oxford Nanopore Technologies Plc (Oxford Nanopore), formerly Oxford NanoLabs Ltd, develops disruptive, electronic, and single-molecule sensing systems. The company’s products include SmidgION, Flongle, MinION, PromethION and GridION used for the analysis of DNA, RNA, proteins, small molecules and other types of molecules. Its products find applications in various areas of research such as microbiology, environmental research, microbiome, basic genome research, human genetics, cancer research, clinical research, plant research, transcriptome analysis, population genomics and animal research. The company also offers support, certification and training services. It works in partnership with various academic and industry research groups to launch new genomic and medical applications through its nanopore technology. Oxford Nanopore is headquartered in Oxford, England, the UK.

Oxford Nanopore Technologies Plc Key Recent Developments

  • Apr 12, 2024: New nanopore-based research unlocks insights into disease and longevity
  • Apr 05, 2024: Oxford Nanopore releases Short Fragment Mode: a new tool for real-time sequencing of short fragments of DNA
  • Mar 11, 2024: Oxford Nanopore Technologies and SeqOne Partner to Support Interpretation of Nanopore Sequencing in Clinical Use
  • Mar 07, 2024: Oxford Nanopore launches PromethION 2 Integrated into open early access

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Oxford Nanopore Technologies Plc - Key Facts
  • Oxford Nanopore Technologies Plc - Key Employees
  • Oxford Nanopore Technologies Plc - Key Employee Biographies
  • Oxford Nanopore Technologies Plc - Major Products and Services
  • Oxford Nanopore Technologies Plc - History
  • Oxford Nanopore Technologies Plc - Company Statement
  • Oxford Nanopore Technologies Plc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Oxford Nanopore Technologies Plc - Business Description
  • Business Segment: COVID-19 Testing
  • Overview
  • Performance
  • Business Segment: Life Science Research Tools (LSRT)
  • Overview
  • Performance
  • Geographical Segment: Americas
  • Performance
  • Geographical Segment: APAC
  • Performance
  • Geographical Segment: EMEAI
  • Performance
  • R&D Overview
  • Oxford Nanopore Technologies Plc - Corporate Strategy
  • Oxford Nanopore Technologies Plc - SWOT Analysis
  • SWOT Analysis - Overview
  • Oxford Nanopore Technologies Plc - Strengths
  • Oxford Nanopore Technologies Plc - Weaknesses
  • Oxford Nanopore Technologies Plc - Opportunities
  • Oxford Nanopore Technologies Plc - Threats
  • Oxford Nanopore Technologies Plc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Oxford Nanopore Technologies Plc, Medical Equipment, Deals By Year, 2018 to YTD 2024
  • Oxford Nanopore Technologies Plc, Medical Equipment, Deals By Type, 2018 to YTD 2024
  • Oxford Nanopore Technologies Plc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Apr 12, 2024: New nanopore-based research unlocks insights into disease and longevity
  • Apr 05, 2024: Oxford Nanopore releases Short Fragment Mode: a new tool for real-time sequencing of short fragments of DNA
  • Mar 11, 2024: Oxford Nanopore Technologies and SeqOne Partner to Support Interpretation of Nanopore Sequencing in Clinical Use
  • Mar 07, 2024: Oxford Nanopore launches PromethION 2 Integrated into open early access
  • Feb 29, 2024: Oxford Nanopore Technologies Announces Directorate Change
  • Jan 22, 2024: Oxford Nanopore Technologies Announces Expansion of Leadership Team
  • Jan 09, 2024: Oxford Nanopore Technologies : FY23 Trading Update
  • Dec 19, 2023: Oxford Nanopore Technologies Appoints Two Non-executive Directors
  • Dec 07, 2023: Oxford Nanopore Technologies - Nanopore Community Meeting Technology Update
  • Nov 30, 2023: New Genomic Funding Awarded in Australia to Boost National Rare Disease Research Programme, Using Oxford Nanopore Technologies
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Oxford Nanopore Technologies Plc, Key Facts
  • Oxford Nanopore Technologies Plc, Key Employees
  • Oxford Nanopore Technologies Plc, Key Employee Biographies
  • Oxford Nanopore Technologies Plc, Major Products and Services
  • Oxford Nanopore Technologies Plc, History
  • Oxford Nanopore Technologies Plc, Subsidiaries
  • Oxford Nanopore Technologies Plc, Key Competitors
  • Oxford Nanopore Technologies Plc, Ratios based on current share price
  • Oxford Nanopore Technologies Plc, Annual Ratios
  • Oxford Nanopore Technologies Plc, Annual Ratios (Cont...1)
  • Oxford Nanopore Technologies Plc, Annual Ratios (Cont...2)
  • Oxford Nanopore Technologies Plc, Interim Ratios
  • Oxford Nanopore Technologies Plc, Medical Equipment, Deals By Year, 2018 to YTD 2024
  • Oxford Nanopore Technologies Plc, Medical Equipment, Deals By Type, 2018 to YTD 2024
  • Oxford Nanopore Technologies Plc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Oxford Nanopore Technologies Plc, Performance Chart (2019 - 2023)
  • Oxford Nanopore Technologies Plc, Ratio Charts
  • Oxford Nanopore Technologies Plc, Medical Equipment, Deals By Year, 2018 to YTD 2024
  • Oxford Nanopore Technologies Plc, Medical Equipment, Deals by Type, 2018 to YTD 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Illumina Inc
  • Source BioScience (Healthcare) Ltd
  • Pacific Biosciences of California Inc
  • Roche Diagnostics International Ltd
  • NanoString Technologies Inc
  • Quest Diagnostics Inc
  • Exact Sciences Corp
  • Adaptive Biotechnologies Corp